Earlier this year Centrosolar flagged up a potential sale of profit-making as part of its broader restructuring plan, which will see Centrosolar itself shift its focus largely to the US.
Renusol has maintained its industry presence and R&D efforts to a large degree throughout Centrosolar's troubles.
After debts and other financial issues are accounted for, the deal will net €2.6m ($3.5m)
